This annual report for the "Talk. They Hear You." Parent-Oriented National Media Campaign highlights the campaign's history and progress in 2019.

This report provides an update on a series of topics focusing on substance use and mental health (collectively referred to as behavioral health) in the United States. SAMHSA selected specific topics and indicators in this report to represent a cross-section of the key behavioral health indicators that are assessed in SAMHSA data collections, including NSDUH. This report is intended to provide a concise, reader-friendly summary of key behavioral health measures for lay and professional audiences.

This Guidance document gives a “bird’s eye view” of strategies to support best practice prescribing of antipsychotics for youth and summarizes the available evidence and principles to support these strategies.

This guide provides information and practices that behavioral health providers can implement in their daily practice with patients or clients who are involved in the criminal justice system.

This annual report for the "Talk. They Hear You." Parent-Oriented National Media Campaign highlights the campaign's history and progress in 2018.

This annual report for the "Talk. They Hear You." Parent-Oriented National Media Campaign highlights the campaign's history and progress in 2017.

This material is an addendum to the 2018 annual report for the "Talk. They Hear You." Parent-Oriented National Media Campaign.

The report highlights the need for HIV treatment providers to address behavioral health concerns with HIV. The report urges providers to start with screening for mental health and substance use disorders, and offers strategies for providers to implement screening practices.

This manual offers guidance on how to engage youth during government-sponsored events and meetings. It includes resources to support youth services, youth development, youth leadership, civic engagement, and youth organizing.

This advisory summarizes data on the use of sublingual and transmucosal buprenorphine for the medication-assisted treatment of opioid use disorder.